News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Anagenics.
RELATED STOCKHEAD STORIES
News
Weekly ASX small cap wrap: ‘Biscuit diplomacy’ is now a thing
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
ATO blocks biotech access to Jobkeeper wage subsidy
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Cancer clinical trials continue as others are shut down on COVID-19 fears
News
Here’s where Predictive Discovery’s 733pc rise in 1 day sits in the record books
Health & Biotech
Zelira, PolyNovo prove even a pandemic can’t stand in the way of good clinical results
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Industry, govt want COVID-19 testing kits as ‘immunity passports’ gain momentum
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
News
Weekly ASX small cap wrap: Who’s bagging the small cap gains this week?
News
March Winners Column: Which stocks do investors choose when the world is in lockdown?
News
Going Viral: All the COVID news you want to read this week
News
Lunchtime ASX small cap wrap: Who’s getting cabin fever today?
Health & Biotech
Cellmid shares jump after securing deal on Chinese COVID-19 testing kits
News
10 at 10: These ASX stocks are on a victory lap this morning
News
